Lacosamide Amarox

Lacosamide, the active ingredient in Lacosamide Amarox, is a sodium channel blocker presented as a tablet for oral use. It is indicated for the management of partial‑onset (focal) seizures in patients diagnosed with epilepsy, helping to reduce seizure frequency when used alone or as add‑on therapy.

GNH USA supplies Lacosamide Amarox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and reliable delivery across global markets while adhering to stringent regulatory standards and providing comprehensive procurement support.

Lacosamide is an antiepileptic drug that modulates neuronal sodium channels to control seizure activity.

- Partial-onset seizures: Reduces seizure frequency as adjunctive therapy in patients with focal epilepsy. - Adjunctive therapy for refractory epilepsy: Enhances overall seizure control when combined with other antiseizure medications. - Focal seizures in adults and children: Provides effective seizure reduction across age groups when prescribed appropriately.

Lacosamide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Nausea - Headache - Fatigue - Blurred vision

Serious or Rare Side Effects: - Cardiac conduction abnormalities (e.g., PR‑interval prolongation) - Severe skin reactions such as Stevens‑Johnson syndrome - Suicidal thoughts or behavior - Hypersensitivity reactions including anaphylaxis

When prescribing Lacosamide, clinicians should consider several precautionary measures to ensure patient safety.

- Renal impairment: Adjust dosing or monitor renal function in patients with reduced clearance. - Hepatic impairment: Evaluate liver function and consider dose modification in severe hepatic disease. - Cardiac conduction disorders: Monitor ECG for PR‑interval changes, especially in patients with pre‑existing heart block. - Pregnancy: Use only if the potential benefit justifies the potential risk, as safety data are limited. - Concomitant antiepileptic drugs: Observe for altered efficacy or increased side effects when combined with other seizure medications. - Store at below 25°C: Keep in the original packaging, protect from moisture and direct sunlight.

Lacosamide can interact with other medicines, affecting its plasma levels or cardiac safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): May increase lacosamide concentrations, raising toxicity risk. - Drugs that prolong PR interval (e.g., class IA antiarrhythmics): Combined use can exacerbate cardiac conduction delays.

Moderate Interactions (Monitor Closely): - Carbamazepine: May reduce lacosamide effectiveness by inducing metabolism. - Phenytoin: Can alter lacosamide plasma levels, requiring clinical monitoring. - Alcohol: May enhance central nervous system depression, increasing dizziness or drowsiness.